Researchers say findings suggest it may be possible to stop cancer growth using approaches such as restraining TE activity in ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

The discussion covered emerging biologics, AI applications, and a strategy for supporting biomanufacturing in the current political climate.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

Unlike traditional microscopes that use light or lenses, DNA microscopy creates images by calculating interactions among ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Study found that reduced neurotensin in obese mice prevented dopamine from triggering the usual pleasure response to ...